Navegar por autor "Anido Herranz, Urbano"

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study

2013- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients

2013- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC): Preliminary analysis of a randomized placebo controlled phase II trial (MAJA trial)-SOGUG 2011-02

2015- Anido Herranz, Urbano

MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlled phase II trial. SOGUG 2011-02. EudraCT 2011-001271-39

2015- Anido Herranz, Urbano

Metastatic and unresectable biliary tract tumors: A single-center retrospective review

2012- Anido Herranz, Urbano; Vieito Villar, María; Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; López López, Rafael; [et al.]

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study

2012- Anido Herranz, Urbano; León Mateos, Luis Ángel; Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; López López, Rafael; [et al.]

Molecular expression profiling and pathway analysis in human renal cell carcinoma

2012- Antón Aparicio, Luis Miguel; Anido Herranz, Urbano

Paclitaxel and Irinotecan in Platinum Refractory/Resistant Small Cell Lung Cancer: Final Analisis of One Galician Lung Cancer Group Experience

2015- Anido Herranz, Urbano; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Covela Rúa, Marta; [et al.]

Phase II study of weekly cabazitaxel for

2013- Anido Herranz, Urbano; Fernández Calvo, Ovidio

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Nuñez, Natalia; García Mata, Jesús; Firvida Perez, Jose Luis; [et al.]

Profiling signaling pathways in formalinfixed and paraffin-embedded renal cell carcinoma tissues

2012- Antón Aparicio, Luis Miguel; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; Santamarina Cainzos, Isabel; Anido Herranz, Urbano [et al.]

Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer

2013- Padin Iruegas, Maria Elena; Herranz Carnero, Michel; Aguin Losada, Santiago; Brozos Vázquez, Elena María; Anido Herranz, Urbano; [et al.]

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Lazaro Quintela, Martín; Vázquez Estévez, Sergio [et al.]

Retrospective study of febrile neutropenia

2012- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: A report of three cases

2012- Anido Herranz, Urbano; León Mateos, Luis Ángel; López López, Rafael; Areses Manrique, María Carmen; Bernárdez Ferrán, Beatriz; [et al.]

The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; Santamarina Cainzos, Isabel; [et al.]

Tissue array analysis in patients with renal cancer

2012- Abdulkader Nallib, Ihab; Anido Herranz, Urbano; Areses Manrique, María Carmen

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

2013- Gómez Veiga, Francisco; Anido Herranz, Urbano; Gómez Caamaño, Antonio; Rodriguez Iglesias, Benito

The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

2020- Carretero-Gonzalez, A.; Lora, D.; Sobrino, I. M.; Sanz, I. S.; Bourlon, M. T.; [et al.]

Weekly cabazitaxel in "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial

2015- Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel

O repositorio dixital RUNA

Navegar por autor "Anido Herranz, Urbano"

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study ﻿

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients ﻿

Maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC): Preliminary analysis of a randomized placebo controlled phase II trial (MAJA trial)-SOGUG 2011-02 ﻿

MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlled phase II trial. SOGUG 2011-02. EudraCT 2011-001271-39 ﻿

Metastatic and unresectable biliary tract tumors: A single-center retrospective review ﻿

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study ﻿

Molecular expression profiling and pathway analysis in human renal cell carcinoma ﻿

Paclitaxel and Irinotecan in Platinum Refractory/Resistant Small Cell Lung Cancer: Final Analisis of One Galician Lung Cancer Group Experience ﻿

Phase II study of weekly cabazitaxel for ﻿

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study. ﻿

Profiling signaling pathways in formalinfixed and paraffin-embedded renal cell carcinoma tissues ﻿

Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer ﻿

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer ﻿

Retrospective study of febrile neutropenia ﻿

Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: A report of three cases ﻿

The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma ﻿

Tissue array analysis in patients with renal cancer ﻿

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study ﻿

The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials ﻿

Weekly cabazitaxel in "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial ﻿

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients

Maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC): Preliminary analysis of a randomized placebo controlled phase II trial (MAJA trial)-SOGUG 2011-02

MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlled phase II trial. SOGUG 2011-02. EudraCT 2011-001271-39

Metastatic and unresectable biliary tract tumors: A single-center retrospective review

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study

Molecular expression profiling and pathway analysis in human renal cell carcinoma

Paclitaxel and Irinotecan in Platinum Refractory/Resistant Small Cell Lung Cancer: Final Analisis of One Galician Lung Cancer Group Experience

Phase II study of weekly cabazitaxel for

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

Profiling signaling pathways in formalinfixed and paraffin-embedded renal cell carcinoma tissues

Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

Retrospective study of febrile neutropenia

Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: A report of three cases

The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma

Tissue array analysis in patients with renal cancer

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

Weekly cabazitaxel in "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial